Table 1.
Predicted viral set points at individual times of the leave-one-out cross-validation and the independent test
| Leave-one-out cross-validation | Measured viral set point | ||||||
| Enrol. | Week 1 | Week 2 | Week 4 | Week 12 | Week 24 | ||
| Subject A | NA | 4.35 | 4.92 | 4.78 | 4.76 | 5.01 | 4.92 |
| Subject B | 4.38 | NA | NA | 4.47 | 4.23 | 4.31 | 4.12 |
| Subject C | 3.76 | 3.97 | NA | NA | 3.44 | 3.62 | 3.56 |
| Subject D | 4.94 | 4.88 | 4.93 | 4.99 | 4.83 | 5.13 | 5.12 |
| Subject E | 4.82 | 4.68 | NA | NA | 4.94 | NA | 4.66 |
| Subject F | 5.06 | 5.16 | 4.82 | 5.10 | 5.04 | 4.77 | 5.20 |
| Subject G | 4.05 | 4.54 | 4.72 | 4.13 | 4.40 | 3.99 | 3.96 |
| Subject H | 5.01 | 5.15 | 5.04 | 4.97 | 4.92 | 5.35 | 5.19 |
| Subject I | 4.89 | 5.06 | 5.22 | 5.03 | 5.17 | 5.11 | 5.34 |
| Subject J | 4.01 | NA | NA | 4.26 | 4.14 | NA | 3.82 |
| Independent validation on Malawian data | Measured viral set point | ||||||
| Enrol. | Week 1 | Week 2 | Week 4 | Week 12 | Week 24 | ||
| Subject 1 | 3.06 | 3.70 | NA | NA | NA | 4.28 | 3.79 |
| Subject 2 | 3.69 | NA | NA | 3.49 | 3.47 | 4.00 | 3.51 |
| Subject 3 | 3.92 | NA | 4.14 | 4.06 | 3.67 | 4.53 | 4.51 |
| Subject 4 | 4.30 | 4.51 | 4.36 | 3.77 | 4.73 | 4.89 | 4.97 |
| Subject 5 | 4.82 | 4.93 | 4.70 | 5.08 | NA | 4.71 | 5.43 |
| Subject 6 | 4.12 | 4.13 | 3.95 | 4.02 | 3.62 | 4.32 | 3.67 |
| Subject 7 | 5.06 | 5.50 | 4.97 | 5.78 | 5.15 | 5.50 | 5.76 |
| Subject 8 | NA | NA | NA | NA | 3.92 | NA | 4.30 |
| Subject 9 | NA | 3.79 | NA | 3.83 | 3.84 | NA | 3.42 |
| Subject 10 | 2.29 | 3.43 | NA | NA | NA | NA | 2.19 |
Note: The not available entries are due to lack of quality RNA samples for gene expression assessment.